Tirzepatide, a dual GIP/GLP-1 receptor agonist approved for diabetes management and weight loss, works through distinct mechanisms from testosterone replacement therapy (TRT), which restores physiological hormone levels in men with confirmed low testosterone
LAST CHANCE
Injections Typically, injections for this treatment are made at areas of the body that have higher fatty tissue, such as the arms, thighs, buttocks, hips, or abdomen
I verify sources, protocol interpretation, and final judgments personally
Make sure to gather the skin and hold it gently while giving the injection
The industry has a real obligation to hold itself to the highest standard of quality, testing, and transparency